Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Andrews

Showing results (731-740 of 875) with videos related to

Pageof 88
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 28, 2016
Optimism, Cynical Hostility, Falls, and Fractures: The Women's Health Initiative Observational Study (WHI-OS)Jane A Cauley, Stephen F Smagula, Kathleen M Hovey, et al.
JAMA Neurology|October 17, 2022
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A ReviewJeremy M Shefner, Richard Bedlack, Jinsy A Andrews, et al.
Nature Communications|April 22, 2026
Suppression of astrocyte BMP signaling improves molecular signatures and functional deficits in a fragile X syndrome mouse modelJames Deng, Adrien Paumier, Lara Labarta-Bajo, et al.
Ophthalmology|April 4, 2026
Towards an Era of Oculomics: The Relationship Between Baseline Severity of Diabetic Retinopathy and Risk of MortalityStephanie S Lee, Shikha Marwah, Sandeepkumar Gaddam, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2015
Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative StudyCarolyn J Crandall, Kathleen M Hovey, Christopher A Andrews, et al.
Biomedicines|December 30, 2025
Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALSNamita A Goyal, Jinsy A Andrews, Björn E Oskarsson, et al.
Menopause (New York, N.Y.)|August 18, 2017
Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational StudyCarolyn J Crandall, Kathleen M Hovey, Christopher A Andrews, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2003
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growthPaul L Leong, Genevieve A Andrews, Daniel E Johnson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 5, 2021
Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of <i>reldesemtiv</i> in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trialStacy A Rudnicki, Jinsy A Andrews, Angela Genge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injuryLiudmila Kulik, Sherry D Fleming, Chantal Moratz, et al.
Pageof 88

Showing results (731-740 of 875) with videos related to

Sort By:
Pageof 88
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 28, 2016
Optimism, Cynical Hostility, Falls, and Fractures: The Women's Health Initiative Observational Study (WHI-OS)Jane A Cauley, Stephen F Smagula, Kathleen M Hovey, et al.
JAMA Neurology|October 17, 2022
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A ReviewJeremy M Shefner, Richard Bedlack, Jinsy A Andrews, et al.
Nature Communications|April 22, 2026
Suppression of astrocyte BMP signaling improves molecular signatures and functional deficits in a fragile X syndrome mouse modelJames Deng, Adrien Paumier, Lara Labarta-Bajo, et al.
Ophthalmology|April 4, 2026
Towards an Era of Oculomics: The Relationship Between Baseline Severity of Diabetic Retinopathy and Risk of MortalityStephanie S Lee, Shikha Marwah, Sandeepkumar Gaddam, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2015
Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative StudyCarolyn J Crandall, Kathleen M Hovey, Christopher A Andrews, et al.
Biomedicines|December 30, 2025
Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALSNamita A Goyal, Jinsy A Andrews, Björn E Oskarsson, et al.
Menopause (New York, N.Y.)|August 18, 2017
Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational StudyCarolyn J Crandall, Kathleen M Hovey, Christopher A Andrews, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2003
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growthPaul L Leong, Genevieve A Andrews, Daniel E Johnson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 5, 2021
Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of <i>reldesemtiv</i> in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trialStacy A Rudnicki, Jinsy A Andrews, Angela Genge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injuryLiudmila Kulik, Sherry D Fleming, Chantal Moratz, et al.
Pageof 88